Dr. James Robert Nobles Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Alex City, AL 35010 Phone: 256-329-9064 Fax: 256-329-0262 |
News Archive
Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
New nanotechnology paints for walls, ceilings, and surfaces could be used to kill hospital superbugs when fluorescent lights are switched on, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Someday your doctor may be able to examine your infant, notice a telltale physical characteristic and say, "Your child has autism — but we've caught it early, so don't worry."
› Verified 6 days ago